About CSL Seqirus Canada
CSL Seqirus has a track record of helping to protect Canadians from seasonal influenza and the threat of global influenza pandemics. We have provided more than 20 million influenza vaccine doses to Canadians since 2010.
CSL Seqirus supports Canada’s public health focus on seasonal influenza vaccination and works to help ensure the success of those programs. As a long-standing partner to Canada’s pandemic planning, we hold the contract as the contingency supplier of influenza pandemic vaccines to the Canadian Government in the event of an influenza pandemic.
Our presence across three continents, allows us to offer advanced insights on the Southern Hemisphere’s influenza season to inform Canada’s approach to seasonal influenza vaccination. CSL Seqirus Canada’s core team is based in Montreal, with individuals working across the country.